The biotech will stop developing two drugs and lay off nearly three-quarters of its staff after its lead therapy wasn’t as ...

The GLP-1s include semaglutide (Ozempic, Wegovy) and the combination of GLP-1/GIP drug tirzepatide (Mounjaro, Zepbound).

IGM Biosciences is again cutting staff as it scraps an autoimmune-drug trial after failing to achieve the desired results.

Osteopathy is a medical field that takes a holistic approach to the treatment of illness and injury. Considered a form of ...

Attendance Allowance is for older people who have a health condition and need help to look after them, however the level of ...